Delivery Order SPE2DB22D1041-SPE2DB25FUCJ5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Azelastine HCL 0.05% ophthalmic drops in 6ml units, valued at $2,620.74. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $119.60 to Amerisourcebergen Drug Corporation for 4561435749 AZELASTINE HCL 0.05% drops, 6mL. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 10, 2023 to support Defense Logistics Agency requirements. The parent company, Amerisourcebergen Corporation, will perform through its Amerisourcebergen division. No...
- This is a $1,565.09 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Azelastine HCL 0.05% eye drops, a medication used to treat eye allergies. The order has a completion date of July 1, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which...
- The Defense Logistics Agency awarded a $3,541.53 delivery order to AmerisourceBergen Drug Corp for Azelastine 0.1% (137 MCG) spray in 30ML quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a child order under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- Defense Logistics Agency awarded a $266 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4562143245 AZELASTINE HCL 0.05% DROPS 6ML. As the parent company, Amerisourcebergen Corporation will perform the order through its Corporate Office location in Conshohocken, Pennsylvania by the required completion date of September 13, 2023. No set-aside designation was applied. This order is likely associated with DLA's medical supply program to support the U.S. military and will deliver...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $358.80 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4562122553 AZELASTINE HCL 0.05% DROPS 6ML to be delivered to a location in Conshohocken, Pennsylvania. The period of performance for this order is September 11-12, 2023. No major subcontractors or set aside designations were indicated. This order was issued under an existing DLA medical supply vehicle to...
- The Defense Logistics Agency awarded a $168,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561976215 AZELASTINE HCL 0.05% DROPS 6ML. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania under a one-day period of performance starting and ending on August 29-30, 2023. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,523.57, is for the delivery of Azelastine 0.1% eye drops. The contract is a Firm Fixed Price Delivery Order with a completion date of June 26, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $1,190.29 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5ml units. This is a non-set-aside competitive award with an ultimate completion date of August 27, 2025, and performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a Delivery Order contract valued at $2,228.42 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops in 5ml units. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure, with an ultimate completion date of August 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUCJ5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azelastine HCL 0.05% ophthalmic drops (6ml units) with a ceiling value of $1,809.36. This non-competitive, firm fixed-price delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025. The product will be delivered from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in federal medical procurement for military and veteran healthcare systems. As a critical vendor for the Defense Logistics Agency, the company supplies an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The award of this delivery order demonstrates AmerisourceBergen's continued capability to fulfill specialized pharmaceutical supply requirements for federal healthcare operations on a rapid turnaround basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/24/25 |